+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Biodel Inc. (BIOD) - Financial and Strategic SWOT Analysis Review

  • ID: 2081861
  • SWOT Analysis
  • February 2016
  • 49 pages
  • GlobalData
1 of 4
Biodel Inc. (BIOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biodel Inc. (Biodel) is a specialty biopharmaceutical company that focuses on the development and commercialization of innovative product candidates for treating diabetes. The company develops products based on its formulation technologies to existing drugs in order to enhance their therapeutic profiles. Biodel’s lead product candidate is a glucagon emergency management (GEM) device, which is intended to treat diabetes patients experiencing very low concentrations of blood glucose.

Biodel Inc. Key Recent Developments

Jan 29,2016 Biodel Announces Restructuring Update
Dec 17,2015 Biodel Reports Fourth Quarter and Fiscal Year 2015 Financial Results
Aug 13,2015 Biodel Reports Third Quarter Fiscal Year 2015 Financial Results
May 18,2015 Biodel Appoints Ms. Arlene M. Morris to Its Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 4

Loading
LOADING...

3 of 4
List of Tables

List of Figures

Section 1 - About the Company

Biodel Inc. - Key Facts

Biodel Inc. - Key Employees

Biodel Inc. - Key Employee Biographies

Biodel Inc. - Major Products and Services

Biodel Inc. - Pharmaceutical Pipeline Products Data

Biodel Inc., Pipeline Products by Therapy Area

Biodel Inc., Pipeline Products by Development Phase

Biodel Inc. - Medical Equipment Pipeline Products Data

Biodel Inc. Pipeline Products by Equipment Type

Biodel Inc. - History

Biodel Inc. - Company Statement

Biodel Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Biodel Inc. - Business Description

Biodel Inc. - Corporate Strategy

Biodel Inc. - SWOT Analysis

SWOT Analysis - Overview

Biodel Inc. - Strengths

Strength - Focused Research Activities

Strength - Proprietary Technology

Strength - Lead Product: GEM

Biodel Inc. - Weaknesses

Weakness - Lack of Marketed Products

Weakness - Dependence on Third Parties

Weakness - Clinical Discontinuations

Biodel Inc. - Opportunities

Opportunity - Growing Aged Population

Opportunity - Strategic Agreements

Opportunity - Growing Incidence of Diabetes

Biodel Inc. - Threats

Threat - Competition

Threat - Uncertain R&D Outcomes

Threat - Patent Infringement

Biodel Inc. - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Biodel Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Biodel Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Biodel Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016

Biodel Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016

Biodel Inc., Recent Deals Summary

Section 5 – Company’s Recent Developments

Jan 29, 2016: Biodel Announces Restructuring Update

Dec 17, 2015: Biodel Reports Fourth Quarter and Fiscal Year 2015 Financial Results

Aug 13, 2015: Biodel Reports Third Quarter Fiscal Year 2015 Financial Results

May 18, 2015: Biodel Appoints Ms. Arlene M. Morris to Its Board of Directors

May 06, 2015: Biodel Reports Second Quarter Fiscal Year 2015 Financial Results

Feb 12, 2015: Biodel Reports First Quarter Fiscal Year 2015 Financial Results

Section 6 – Appendix

Methodology

Ratio Definitions

About us

Contact Us

Disclaimer

List of Tables

Biodel Inc., Key Facts

Biodel Inc., Key Employees

Biodel Inc., Key Employee Biographies

Biodel Inc., Major Products and Services

Biodel Inc., Number of Pipeline Products by Therapy Area

Biodel Inc., Number of Pipeline Products by Development Stage

Biodel Inc., Pipeline Products By Therapy Area and Development Phase

Biodel Inc. Number of Pipeline Products by Equipment Type

Biodel Inc. Pipeline Products by Equipment Type

Biodel Inc. Pipeline Products by Development Stage

Biodel Inc., History

Biodel Inc., Other Locations

Biodel Inc., Subsidiaries

Biodel Inc., Key Competitors

Biodel Inc., Ratios based on current share price

Biodel Inc., Annual Ratios

Biodel Inc., Interim Ratios

Biodel Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Biodel Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Biodel Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016

Biodel Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016

Biodel Inc., Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Biodel Inc., Pipeline Products by Therapy Area

Biodel Inc., Pipeline Products by Development Phase

Biodel Inc. Pipeline Products by Equipment Type

Biodel Inc., Performance Chart (2011 - 2015)

Biodel Inc., Ratio Charts

Biodel Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Biodel Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Biodel Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016

Biodel Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll